Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

BACKGROUND: Patients with high-frequency episodic migraine (HFEM) have a greater disease burden than those with low-frequency episodic migraine (LFEM). Acute treatment overuse increases the risk of migraine chronification in patients with HFEM. Galcanezumab, a humanized monoclonal antibody binding c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Headache Pain
Main Authors: Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Milan 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734504/
https://ncbi.nlm.nih.gov/pubmed/31253091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-019-1024-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados